Featured / Jan 27

Coronavirus disease (COVID-19) update

As Novartis continues to closely monitor the coronavirus situation, our primary concern is the health and safety of our associates and patients globally. We will continue to deliver our medicines to patients around the world and we do not anticipate supply chain disruption at this time.

See our product listing, including: NDCs, Size, Dosage Forms and more.